Mr. Jia Li has more than 15 years experience in pharmaceutical and biotechnology industries with creasing levels of responsibilities in Business Development, Sales and R&D.
He is the CEO of Yifan International from January 2021 to present. He held the Head of Business Development at YiFan China (2019 to 2020), with strong track record of transactions with multi-national pharmaceutical companies on China market, creating significant revenue growth.
He held the Group Lead at Novozymes China to generating scifitic data and contributing in new product development and global launch.